ESR1 and breast cancer: The localization of Gli-1, nevertheless, has raised a debate over its overexpression and the presence or absence of hormone receptors in breast cancer [30,45,50], with some studies reporting a correlation between the nuclear localization of Gli-1 and ER status [30], some linking Shh expression and ER-alpha in particular [51,52].